e-learning
resources
Munich 2006
Sunday 03.09.2006
Recent update on asthma treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Efficacy of antiepileptic drugs diphenine and carbamazepine in pharmacotherapy of children with bronchial asthma: is asthma a neurogenic inflammatory disease?
M. Lomia, T. Tchelidze, M. Pruidze (Tbilisi, Georgia)
Source:
Annual Congress 2006 - Recent update on asthma treatment
Session:
Recent update on asthma treatment
Session type:
Thematic Poster Session
Number:
1225
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Lomia, T. Tchelidze, M. Pruidze (Tbilisi, Georgia). Efficacy of antiepileptic drugs diphenine and carbamazepine in pharmacotherapy of children with bronchial asthma: is asthma a neurogenic inflammatory disease?. Eur Respir J 2006; 28: Suppl. 50, 1225
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Efficacy of monotherapy with anticonvulsive drugs topiramate and carbamazepine in bronchial asthma: is asthma a neurological disease?
Source: Eur Respir J 2004; 24: Suppl. 48, 130s
Year: 2004
Bronchial asthma as neurogenic inflammatory and paroxysmal disease – efficacy of antiepileptic drug diphenine in asthma therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 316s
Year: 2006
Bronchial asthma as neurogenic paroxysmal inflammatory disease - high efficacy of antiepileptic drug oxcarbazepine in asthma monotherapy
Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Year: 2005
Bronchial asthma as neurogenic paroxysmal disease - high effectiveness of carbamazepine in asthma monotherapy
Source: Eur Respir J 2004; 24: Suppl. 48, 221s
Year: 2004
Pharmacogenetics of anti-inflammatory treatment in children with asthma
Source: Annual Congress 2013 –Towards personalised medicine in respiratory diseases in children
Year: 2013
Response of children with bronchial asthma to combined therapy with an oral immunostimulating drug and antileukotrienes
Source: Eur Respir J 2005; 26: Suppl. 49, 159s
Year: 2005
Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Features of anti-inflammatory therapy of bronchial asthma in children with overweight andobesity
Source: Virtual Congress 2020 – Paediatric asthma
Year: 2020
Combination asthma medication and healthcare use in severe or difficult-to-treat asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004
Immunological effectiveness of atorvastatin in complex therapy of severe persistent bronchial asthma
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009
Pharmacogenetics of inhaled corticosteroid response in adults with asthma
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020
An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019
Efficacy of the long-term therapy with simbicort in children with bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 395s
Year: 2005
The cost-efficacy of combined anti-inflammatory therapy in the treatment of children in severe persistent asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 134s
Year: 2003
Azithromycin in the anti-inflammatory treatment of children with asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 167s
Year: 2004
Update on anti-inflammatory therapy in asthma
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
Source: Breathe 2010; 6: 365
Year: 2010
Oral corticosteroids in the treatment of exacerbation of severe asthma
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020
Cost of asthma rescue/acute and allergy medications among asthmatic patients on controller therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Year: 2004
Once-daily tiotropium respimat add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept